EUVIMEDEUVIMED entdecken
Crossref

Enhancement of chemoresistance by claudin-1-mediated formation of amino acid barriers in human lung adenocarcinoma A549 cells

Riho Kimura, Shotaro Hashimoto, Hiroaki Eguchi, Yoshifumi Morikawa, Koichi Suenami, Yuta Yoshino, Toshiyuki Matsunaga, Satoshi Endo, Akira Ikari

Archives of Biochemistry and Biophysics · 2024

DOI: 10.1016/j.abb.2024.110106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von Riho Kimura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, 501-1196, Japan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Claudin-1, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Takahashi Industrial and Economic Research Foundation, Smoking Research Foundation, Foundation for Promotion of Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Claudin-1 (CLDN1) is highly expressed in human lung adenocarcinoma-derived A549 cells and is involved in the augmentation of chemoresistance. However, the mechanism of chemoresistance is not fully understood. In the tumor microenvironment, cancer cells are exposed to stress conditions such as hypoxia and malnutrition. Here, we investigated the effect of CLDN1 expression on amino acid (AA) flux and chemoresistance using A549 cells. The expression of L-type AA transporters, LAT1 and LAT3, was decreased by CLDN1 silencing in A549 spheroids. A reduction in extracellular AA concentration increased the expression of these AA transporters in two-dimensional (2D) cultured cells. The paracellular AA flux except for Ser, Thr, Tyr, Ala, and Gly was enhanced by CLDN1 silencing. These results suggest that CLDN1 forms a paracellular barrier to some AAs, leading to the elevation of LAT1/3 expression in spheroids. The production of reactive oxygen species in the mitochondria and cytosol was decreased by CLDN1 silencing in spheroids, resulting in downregulation of the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and its target antioxidant genes. CLDN1 silencing enhanced the cytotoxicity of anticancer drugs including doxorubicin and cisplatin, which was blocked by sulforaphane, an inducer of Nrf2 signaling. Similarly, the anticancer-induced toxicity was enhanced by Nrf2 silencing. In 2D cultured cells, the anticancer-induced toxicity was attenuated by AA deficiency and sulforaphane. We suggest that CLDN1 forms an AA barrier in spheroids, leading to the augmentation of Nrf2-dependent chemoresistance in A549 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmClaudin-1Adenocarcinoma of LungLung NeoplasmsHumansA549 CellsAmino AcidsReactive Oxygen SpeciesLarge Neutral Amino Acid-Transporter 1NF-E2-Related Factor 2Spheroids, CellularGene Silencing

Stichwörter der Autor:innen

Amino acid transportChemoresistanceClaudin-1

Substanzen

Claudin-1CLDN1 protein, humanAmino AcidsReactive Oxygen SpeciesLarge Neutral Amino Acid-Transporter 1NF-E2-Related Factor 2NFE2L2 protein, human

Autor:innen und Institutionen

  • Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, 501-1196, Japan.
  • Forensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu, 500-8501, Japan.
  • Laboratory of Bioinformatics, Gifu Pharmaceutical University, Gifu, 502-8585, Japan.
  • Drug Design Laboratory, Gifu University, Gifu, 501-1194, Japan.
  • Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, 501-1196, Japan. Electronic address: ikari@gifu-pu.ac.jp.

Förderung

  • Takahashi Industrial and Economic Research Foundation
  • Smoking Research Foundation
  • Foundation for Promotion of Cancer Research
  • Kobayashi Foundation for Cancer Research
  • Takeda Science Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Kimura, R., Hashimoto, S., Eguchi, H., Morikawa, Y., Suenami, K., Yoshino, Y., Matsunaga, T., Endo, S., & Ikari, A. (2024). Enhancement of chemoresistance by claudin-1-mediated formation of amino acid barriers in human lung adenocarcinoma A549 cells. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2024.110106

Vancouver

Kimura R, Hashimoto S, Eguchi H, Morikawa Y, Suenami K, Yoshino Y, et al. Enhancement of chemoresistance by claudin-1-mediated formation of amino acid barriers in human lung adenocarcinoma A549 cells. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2024.110106

BibTeX
@article{Kimura2024,
  author = {Kimura, Riho and Hashimoto, Shotaro and Eguchi, Hiroaki and Morikawa, Yoshifumi and Suenami, Koichi and Yoshino, Yuta and Matsunaga, Toshiyuki and Endo, Satoshi and Ikari, Akira},
  title = {Enhancement of chemoresistance by claudin-1-mediated formation of amino acid barriers in human lung adenocarcinoma A549 cells},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1016/j.abb.2024.110106}
}
Kostenlos starten →